While PSA testing has been used for decades for detecting early prostate cancer and monitoring therapy response, PSA levels are significantly affected by age, hypertrophy of the prostate, environmental factors, geography, diet and ethnicity. The gene discussed is KLK3; the disease is prostate carcinoma.